###begin article-title 0
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
Systematic Association Mapping Identifies NELL1 as a Novel IBD Disease Gene
###end article-title 0
###begin p 1
Conceived and designed the experiments: SS JH MA MP MK AF TK CM. Performed the experiments: PR KH AR CB AF AR TB MW GM RL HF CO FW CM NP UR AE RH. Analyzed the data: KH MS MK CB AF RL CO NP. Contributed reagents/materials/analysis tools: SS PN TK. Wrote the paper: AF.
###end p 1
###begin p 2
###xml 476 480 476 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 486 490 486 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5q31</italic>
###xml 540 546 540 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5p13.1</italic>
###xml 632 638 632 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1,</italic>
###xml 650 657 650 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11p15.1</italic>
###xml 928 933 928 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 1032 1037 1032 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 1093 1095 1093 1095 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 1138 1144 1138 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5p13.1</italic>
###xml 1282 1284 1282 1284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 1405 1410 1405 1410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGB6</italic>
###xml 1423 1427 1423 1427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRM8</italic>
###xml 1442 1447 1442 1447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OR5V1</italic>
###xml 1462 1468 1462 1468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPP3R2</italic>
###xml 1483 1492 1483 1492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NM_152575</italic>
###xml 1508 1513 1508 1513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4G</italic>
###xml 1229 1236 <span type="species:ncbi:9606">patient</span>
Crohn disease (CD), a sub-entity of inflammatory bowel disease (IBD), is a complex polygenic disorder. Although recent studies have successfully identified CD-associated genetic variants, these susceptibility loci explain only a fraction of the heritability of the disease. Here, we report on a multi-stage genome-wide scan of 393 German CD cases and 399 controls. Among the 116,161 single-nucleotide polymorphisms tested, an association with the known CD susceptibility gene NOD2, the 5q31 haplotype, and the recently reported CD locus at 5p13.1 was confirmed. In addition, SNP rs1793004 in the gene encoding nel-like 1 precursor (NELL1, chromosome 11p15.1) showed a consistent disease-association in independent German population- and family-based samples (942 cases, 1082 controls, 375 trios). Subsequent fine mapping and replication in an independent sample of 454 French/Canadian CD trios supported the authenticity of the NELL1 association. Further confirmation in a large German ulcerative colitis (UC) sample indicated that NELL1 is a ubiquitous IBD susceptibility locus (combined p<10-6; OR = 1.66, 95% CI: 1.30-2.11). The novel 5p13.1 locus was also replicated in the French/Canadian sample and in an independent UK CD patient panel (453 cases, 521 controls, combined p<10-6 for SNP rs1992660). Several associations were replicated in at least one independent sample, point to an involvement of ITGB6 (upstream), GRM8 (downstream), OR5V1 (downstream), PPP3R2 (downstream), NM_152575 (upstream) and HNF4G (intron).
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 135 138 135 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Loftus1">[1]</xref>
###xml 505 508 505 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Schreiber1">[2]</xref>
###xml 530 533 530 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Orholm1">[3]</xref>
###xml 535 538 535 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Kuster1">[4]</xref>
###xml 604 607 604 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Tysk1">[5]</xref>
###xml 609 612 609 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Thompson1">[6]</xref>
###xml 752 756 752 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 756 759 756 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Ogura1">[7]</xref>
###xml 760 763 760 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Hampe1">[9]</xref>
###xml 765 769 765 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IBD1</italic>
###xml 796 800 796 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5q31</italic>
###xml 802 806 802 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IBD5</italic>
###xml 814 818 814 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Peltekova1">[10]</xref>
###xml 820 824 820 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Rioux1">[11]</xref>
###xml 826 830 826 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLG5</italic>
###xml 830 834 830 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Stoll1">[12]</xref>
###xml 836 840 836 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Biank1">[13]</xref>
###xml 842 849 842 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15</italic>
###xml 849 853 849 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Yamazaki1">[14]</xref>
###xml 855 862 855 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATG16L1</italic>
###xml 862 866 862 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Hampe2">[15]</xref>
###xml 868 873 868 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CARD4</italic>
###xml 873 877 873 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-McGovern1">[16]</xref>
###xml 892 897 892 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 897 901 897 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Duerr1">[17]</xref>
An estimated 1.4 million individuals in the United States and 2.2 million individuals in Europe suffer from inflammatory bowel disease [1] (IBD, MIM 601458, 266600, 191390), a life-long disease that occurs in the form of one of two major sub-phenotypes, Crohn disease (CD) or ulcerative colitis (UC). The pathophysiology of IBD is characterized by a highly activated state of the mucosal immune system and excessive mucosal destruction. The enteric flora appears to play a key role as a stimulating agent [2]. Familial clustering [3], [4] and an increased concordance rate of IBD among monozygotic twins [5], [6] are hallmarks of the genetic aetiology of IBD, a notion that is further supported by the discovery of several disease genes. This includes NOD2[7]-[9] (IBD1), a risk haplotype in the 5q31 (IBD5) locus [10], [11], DLG5[12], [13], TNFSF15[14], ATG16L1[15], CARD4[16], and recently IL23R[17].
###end p 4
###begin p 5
###xml 237 244 237 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15</italic>
###xml 250 254 250 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Yamazaki1">[14]</xref>
###xml 322 327 322 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 327 331 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Duerr1">[17]</xref>
###xml 336 342 336 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5p13.1</italic>
###xml 342 346 342 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Libioulle1">[18]</xref>
###xml 510 517 510 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATG16L1</italic>
###xml 545 549 545 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Hampe2">[15]</xref>
###xml 608 612 608 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Libioulle1">[18]</xref>
###xml 613 617 613 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Prescott1">[21]</xref>
High-density SNP arrays have enabled genome-wide association scans (GWS) to be performed at reasonable costs. Yamazaki and colleagues reported the first GWS for CD, which resulted in the identification of associated polymorphisms in the TNFSF15 gene [14]. Recently, two other GWS reported the novel CD susceptibility loci IL23R[17] and 5p13.1[18]. We recently performed a genome-wide candidate gene analysis, using 19,779 non-synonymous SNPs, which led to the identification of a common variant (T300A) in the ATG16L1 gene as predisposing to CD [15], a finding that was later replicated by four other groups [18]-[21].
###end p 5
###begin p 6
###xml 123 132 123 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000691.s002">Figure S1</xref>
###xml 261 265 259 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Matsuzaki1">[22]</xref>
###xml 316 320 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Fingerlin1">[23]</xref>
###xml 755 759 751 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 761 765 757 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IBD5</italic>
###xml 771 777 767 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5p13.1</italic>
###xml 837 844 833 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11p15.1</italic>
###xml 893 898 889 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 238 243 <span type="species:ncbi:9606">Human</span>
###xml 364 372 <span type="species:ncbi:9606">patients</span>
Here, we report upon the identification of additional risk loci for CD through a multi-stage genome-wide association scan (Figure S1) in 393 German cases and 399 German population-representative controls, using the Affymetrix GeneChip(R) Human Mapping 100K Set [22]. In order to enrich our samples with risk alleles [23] and to reduce phenotypic heterogeneity, CD patients in the GWS were selected for a "severe" phenotype, including a positive IBD family history, age of onset</=25 years, and no change in diagnosis over the last five years. The SNPs representing the top 200 association leads were re-genotyped in both, a large independent German case-control sample and a family-based sample comprising 375 nuclear families. In addition to replicating NOD2, IBD5, and 5p13.1, a novel susceptibility locus was identified on chromosome 11p15.1, namely the nel-like 1 precursor-encoding gene (NELL1).
###end p 6
###begin title 7
Results
###end title 7
###begin title 8
Genome-wide association scan
###end title 8
###begin p 9
###xml 64 71 64 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000691-t001">Table 1</xref>
###xml 218 221 216 219 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HWE</sub>
###xml 243 252 239 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000691.s009">Table S1A</xref>
###xml 482 491 478 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000691.s003">Figure S2</xref>
###xml 592 594 588 590 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 597 599 593 595 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST</sub>
###xml 681 685 677 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Steffens1">[24]</xref>
###xml 873 877 869 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Krawczak1">[25]</xref>
###xml 966 970 962 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Clayton1">[26]</xref>
###xml 1004 1005 998 999 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1018 1027 1012 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000691.s004">Figure S3</xref>
###xml 1208 1212 1202 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Spielman1">[27]</xref>
###xml 692 700 <span type="species:ncbi:9606">patients</span>
A total of 116,161 SNPs were genotyped in case-control panel A (Table 1). Of these, 92,387 SNPs had a call rate>/=90%, were polymorphic in panel A, and showed no significant departure from Hardy-Weinberg equilibrium (pHWE</=0.01 in controls) (Table S1A). At an unadjusted per-test significance level of 5%, the experiment had 80% power to detect an odds ratio of 1.6, and 33% power to detect an odds ratio of 1.3, assuming that 20% of the controls were carriers of the risk factor (Figure S2). The GWS results were not corrected for potential population substructure because (i) very low (<10-3) FST values have previously been reported for different geographic regions of Germany [24], (ii) patients of panel A were all selected from the Northern part of Germany, and were therefore geographically matched to the population-representative controls from the POPGEN biobank [25], (iii) quantile-quantile plots, which can help to identify spurious association results [26], revealed no inflation of the chi2 statistics (Figure S3), and (iv) replication criteria included confirmation by family-based association tests (transmission disequilibrium test, TDT), which are robust against population stratification [27].
###end p 9
###begin title 10
###xml 19 26 <span type="species:ncbi:9606">patient</span>
###xml 52 59 <span type="species:ncbi:9606">patient</span>
Crohn disease (CD) patient, ulcerative colitis (UC) patient, and replication samples used for association analyses.
###end title 10
###begin p 11
###xml 4 11 <span type="species:ncbi:9606">patient</span>
The patient samples were organized in panels that correspond to successive steps of the study. Index cases from trios were also used in the case-control analyses so that, for example, a total of 942 cases (567+375) were available for the case-control comparison in panel B.
###end p 11
###begin title 12
Replication
###end title 12
###begin p 13
###xml 105 113 105 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000691.s010">Table S2</xref>
###xml 253 260 253 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000691-t002">Table 2</xref>
###xml 435 439 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-McIntyre1">[28]</xref>
The 200 most significant SNPs in the GWS were next genotyped in two independent German samples (panel B, Table S2). "Replication" was considered to have been achieved if the p-values of both, the case-control analysis and the family-based TDT were <5% (Table 2). Replication in two independent samples also rendered test-wise Bonferroni correction superfluous, which would have been overly conservative in a replication setting anyway [28].
###end p 13
###begin title 14
Markers showing a significant CD association in the case-control and the family-based analyses in panel B.
###end title 14
###begin p 15
###xml 34 37 34 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCA</sub>
###xml 59 62 59 62 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCG</sub>
###xml 129 132 129 132 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCA</sub>
###xml 135 138 135 138 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCG</sub>
###xml 162 165 162 165 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TDT</sub>
###xml 354 362 354 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000691.s010">Table S2</xref>
###xml 367 369 367 369 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">co</sub>
###xml 377 379 377 379 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ca</sub>
P-values obtained in an allele- (pCCA) or genotype-based (pCCG) case-control comparison in panel A are shown. Also included are pCCA, pCCG, and the TDT results (pTDT) for replication panel B. Nucleotide positions refer to NCBI build 35. Known susceptibility loci for CD are highlighted by bold type. A complete list of all 200 genotyped SNPs is given in Table S2. MAFco and MAFca denote the minor allele frequency in controls and cases, respectively. Rank: rank of SNP according to the p-value obtained in screening panel A. Odds Ratios (OR) and corresponding 95% confidence intervals (95% CI) are given for carriership of the rare allele of each SNP.
###end p 15
###begin p 16
###xml 32 40 32 40 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000691.s010">Table S2</xref>
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5q31</italic>
###xml 81 85 81 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Peltekova1">[10]</xref>
###xml 144 147 144 147 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCA</sub>
###xml 150 153 150 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;12</sup>
###xml 180 184 180 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 184 187 184 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Ogura1">[7]</xref>
###xml 188 191 188 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Hampe1">[9]</xref>
###xml 215 221 215 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5p13.1</italic>
###xml 228 232 228 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Libioulle1">[18]</xref>
###xml 318 323 318 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 601 607 601 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5p13.1</italic>
###xml 635 640 635 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 664 668 664 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IBD5</italic>
###xml 762 765 762 765 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCA</sub>
###xml 770 773 770 773 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCG</sub>
###xml 779 781 777 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 874 879 872 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGB6</italic>
###xml 903 907 901 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRM8</italic>
###xml 934 939 932 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OR5V1</italic>
###xml 965 971 963 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPP3R2</italic>
###xml 1033 1038 1031 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4G</italic>
###xml 1079 1086 1077 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000691-t003">Table 3</xref>
In addition to rs2631372 (#163, Table S2), which localizes to the 5q31 haplotype [10], an association with CD was confirmed for rs2076756 (#1, pCCA<10-12) and rs10521209 (#159) in NOD2[7]-[9]. The recently reported 5p13.1 locus [18] was also replicated (rs1992660/#70, rs1992662/#75), and a novel susceptibility gene, NELL1, was identified (rs1793004/#83). While only these six SNPs were found to be nominally significant in both, the TDT and the case-control analysis, and therefore fulfilled the formal replication criteria, 47 SNPs were significant in only one test, including two more SNPs in the 5p13.1 region (#79, #105), one in NELL1 (#116), and one in the IBD5 region (#191). In view of the low power of the TDT, it appears worth mentioning that use of pCCA or pCCG </=10-2 as the sole replication criterion would have led to the additional acceptance of rs2925757 (ITGB6, upstream), rs6947579 (GRM8, downstream), rs10484545 (OR5V1, downstream), rs4743484 (PPP3R2, downstream), rs7868736 (NM_152575, upstream), and rs830772 (HNF4G, intron) as confirmed associations (see Table 3).
###end p 16
###begin title 17
###xml 70 72 68 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 130 137 128 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000691-t002">Table 2</xref>
Makers that were significant only in the case-control analysis (p</=10-2), but not in the TDT. For column header descriptions see Table 2.
###end title 17
###begin p 18
###xml 61 68 61 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATG16L1</italic>
###xml 68 72 68 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Hampe2">[15]</xref>
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLG5</italic>
###xml 82 86 82 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Stoll1">[12]</xref>
###xml 146 151 146 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 151 155 151 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-McGovern1">[16]</xref>
###xml 186 193 186 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000691-t004">Table 4</xref>
###xml 496 500 496 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLG5</italic>
We did not detect our previously reported CD associations of ATG16L1[15], and DLG5[12] in this screening and did not see any association with and IL23R[16]. As detailed in the legend to Table 4, SNP coverage around these genes was very low. In order to benchmark our experiments, relevant SNPs in these genes were therefore genotyped in panels A and B, using TaqMan technology, and a disease association was observed for SNPs in all three genes. Interestingly, haplotype A-tagging SNP e26 in the DLG5 gene was replicated (over-transmission of common allele T, T:U = 275:219, p = 0.012), while the associations of non-synonymous SNPs Arg30Gln and Pro1371Gln did not reach statistical significance.
###end p 18
###begin title 19
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 48 54 48 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5p13.1</italic>
###xml 144 149 144 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
Summary of association statistics for NELL1 and 5p13.1 SNPs as obtained in individual panels. In addition, results are shown for the two common NELL1 nsSNPs rs8176785 and rs8176786.
###end title 19
###begin p 20
###xml 190 193 190 193 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HWE</sub>
###xml 412 419 412 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000691-t002">Table 2</xref>
Significant association results (p<0.05) are highlighted by bold type. The SNP callrate (CR) is shown for the combined case/control sample, while the p-value of Hardy-Weinberg proportions (pHWE) is shown for controls only. A1 denotes the rare and A2 the more common allele. T:U is times transmitted vs. times non-transmitted and OA denotes the over-transmitted allele. For further column header descriptions see Table 2.
###end p 20
###begin p 21
###xml 87 92 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 97 103 97 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5p13.1</italic>
###xml 320 325 320 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 473 479 473 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5p13.1</italic>
###xml 612 614 612 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 844 845 842 843 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 897 902 895 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 995 1003 993 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000691-t005">Tables 5</xref>
###xml 1008 1009 1006 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000691-t006">6</xref>
To corroborate our main association findings, we examined the significantly associated NELL1 and 5p13.1 SNPs in two additional, independent Caucasian CD samples: Panel D, which comprised population-based Falk-Rubinstein trios from the Quebec founder population (QFP), and panel E, a case-control sample from the UK. The NELL1 association was replicated in the QFP (over-transmission of the common C allele, T:U = 140:107, p = 0.036) sample. In addition, the association of 5p13.1 SNP 1992660 was replicated in the QFP case-control sample (p = 0.0081) and the combined p-value for panels B, D, and E was 1.24 x 10-7 in an allele-based test. The odds ratio for homozygosity of the common A allele was 1.36 (95% CI: 1.36-2.04). In the UK sample (panel E), the associations of SNPs rs1992660 and rs1992662 were replicated with p-values (allelic chi2 test) of 0.036 and 0.0011, respectively, while the NELL1 SNP association did not achieve formal significance. An overview of the results is given in Tables 5 and 6.
###end p 21
###begin title 22
###xml 87 94 87 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000691-t004">Table 4</xref>
Summary of association analyses in combined panels. For column header descriptions see Table 4.
###end title 22
###begin title 23
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 82 86 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLG5</italic>
###xml 88 93 88 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 99 106 99 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATG16L1</italic>
Single-point analysis of relevant SNPs in the known CD susceptibility genes NOD2, DLG5, IL23R, and ATG16L1 carried out in panels A, B, and in the combined panel (A+B).
###end title 23
###begin p 24
###xml 136 140 136 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 142 146 142 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLG5</italic>
###xml 148 153 148 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 159 166 159 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATG16L1</italic>
###xml 367 388 367 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000691.s015">supplementary Table 7</xref>
###xml 431 438 431 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000691-t002">Table 2</xref>
The SNPs were genotyped in addition to the 100k set to benchmark the results against previously published findings. The SNP coverage of NOD2, DLG5, IL23R, and ATG16L1 on the 100k array was scarse with 2, 4, 4, and 0 SNPs located in these genes, respectively. The detailed SNP coverage on the array and their relative position to the SNPs retyped here is presented in supplementary Table 7. For a description of column headers, see Table 2.
###end p 24
###begin title 25
Evaluation in Ulcerative Colitis (UC)
###end title 25
###begin p 26
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5p13.1</italic>
###xml 196 201 196 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 314 315 312 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 481 486 479 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 552 554 550 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 629 635 627 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5p13.1</italic>
###xml 167 175 <span type="species:ncbi:9606">patients</span>
The three SNPs rs1793004 (NELL1), rs1992660, and rs1992662 (both 5p13.1) with a confirmed CD association were also analysed in a German UC panel (panel C, 1059 single patients and 419 trios). The NELL1 SNP rs1793004 also showed a disease association in the UC case-control panel (p = 0.0017 in the allele-based chi2 test) and the odds ratio for homozygosity of the common C allele was 1.54 (95% CI: 1.08-2.20 ). Given the similar odds ratio in UC and CD (1.76; 95% CI: 1.27-2.45), NELL1 appears to be a ubiquitous IBD susceptibility gene (combined p<10-6; OR = 1.66, 95% CI: 1.30-2.11). No association to UC was detected for the 5p13.1 locus.
###end p 26
###begin title 27
Fine mapping around NELL1
###end title 27
###begin p 28
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 129 137 129 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000691-g001">Figure 1</xref>
###xml 139 147 139 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000691.s011">Table S3</xref>
###xml 173 178 173 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 437 442 437 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
Fine mapping around the NELL1 gene was carried out in replication panels B and D using HapMap tagging SNPs at a density of 8 kb (Figure 1, Table S3). Twenty-one SNPs in the NELL1 gene yielded a p-value<0.05 in the single-point analyses of panel B (12 in panel D), of which several markers were significant in both, the TDT and case-control test. Results were not corrected for multiple testing because the association between CD and the NELL1 locus was regarded as established through the previous analyses of panels A and B.
###end p 28
###begin title 29
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
Overview of the CD association findings for the NELL1 gene.
###end title 29
###begin p 30
###xml 303 308 303 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 548 549 548 549 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 690 693 686 689 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HWE</sub>
(A) Plot of the negative natural logarithm of the p-values obtained in the different stages of the study across a 1 Mb region. The red line shows the significance threshold (i.e. p = 0.05). Results for SNP rs1793004 are highlighted in pink. The main replication signal localizes to the 5' region of the NELL1 gene. (B) Plot of the recombination rate (in cM/Mb), showing that the peak replication signal is delineated by two regions of increased recombination. (C, D) Linkage-disequilibrium (LD) plots from HapMap, using metrics D' (section C) and r2 (section D). Genotypes of trios with Northern- and Western-European ancestry were retrieved from HapMap for 1261 SNPs (CR>/=90%, MAF>/=1%, pHWE>/=0.01, Mendel errors</=3). Positions are from NCBI build 35.
###end p 30
###begin p 31
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 60 69 60 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000691-g001">Figure 1B</xref>
###xml 605 610 605 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 667 673 667 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC6A5</italic>
NELL1 comprises several regions of increased recombination (Figure 1B), scattered over a total of 906 kb. Disease associations were found with various small linkage disequilibrium (LD) blocks, suggesting the existence of more than one causal variant in the gene. In a logistic regression analysis of the combined panels A+B, the best model fit was achieved with SNPs rs1793004, rs951199, rs8176785, rs10500885, rs1158547, and rs1945404. The main association peak was located 5' of the gene, although a few significant associations were also found towards the 3' end. The signal sharply declines 5' of the NELL1 gene, thereby excluding an involvement of the proximate SLC6A5 gene. A gender-stratified analysis (data not shown) of the 117 SNPs in panel B confirmed a disease association in both genders.
###end p 31
###begin title 32
Detection of Additional DNA Sequence Variants
###end title 32
###begin p 33
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 233 241 233 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000691.s012">Table S4</xref>
###xml 268 276 268 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000691.s013">Table S5</xref>
###xml 836 845 836 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In-silico</italic>
###xml 1018 1025 1018 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000691.s001">Text S1</xref>
###xml 1030 1039 1030 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000691.s005">Figure S4</xref>
###xml 223 231 <span type="species:ncbi:9606">patients</span>
Since rs1793004 clearly localizes to NELL1, a systematic search for additional, potentially disease-associated variants in the gene was carried out by re-sequencing all exons, splice sites, and the promoter region in 47 CD patients (Table S4; for primer sequences see Table S5). Apart from verifying 26 already annotated variants, five new polymorphisms were identified, two of which represented novel non-synonymous SNPs (nsSNPs): NELL01_02 (R136S) and NELL01_03 (A153T). Both nsSNPs were located in exon 4 and mapped to the thrombospondin N-terminal domain (TSPN) of the NELL1 protein. Two known, common nsSNPs were verified among the 26 annotated SNPs, namely rs8176785 (Q82R) in exon 3 and rs8176786 (R354W) in exon 10. Variant Q82R is located in the TSPN domain, while R354W resides in a von Willebrand factor type C (VWC) domain. In-silico analysis, including multiple sequence alignment of NELL homologues and structural modeling of the TSPN domain, revealed a strong conservation of the variant positions (see Text S1 and Figure S4).
###end p 33
###begin p 34
###xml 474 475 472 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The novel nsSNPs were too rare to warrant formal statistical analysis (total occurrence of heterozygotes in panel B (CD/controls): 2/0 for R136S and 10/9 for A153T). While common nsSNP rs8176786 showed a disease association in panel E (p = 0.048), the second common nsSNP, rs8176785, was significantly associated with CD in panel B (p = 0.039), and with UC in panel C (p = 0.013). The combined p-value in the full German IBD sample (A+B+C) was 0.0048 in a genotype-based chi2 test (2 degrees of freedom).
###end p 34
###begin title 35
Expression and Localization of NELL1 within the Intestinal Mucosa
###end title 35
###begin p 36
###xml 5 10 5 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 275 284 275 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000691-g002">Figure 2A</xref>
###xml 377 394 377 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000691-g002">Figures 2B and 2C</xref>
###xml 573 582 573 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000691-g002">Figure 2E</xref>
###xml 563 571 <span type="species:ncbi:9606">patients</span>
###xml 791 798 <span type="species:ncbi:9606">patient</span>
When NELL1 transcript levels were investigated by RT-PCR in a tissue panel, high expression became apparent in small intestine, kidney, prostate, and brain, whereas moderate expression was seen in colonic mucosa and in immune-relevant organs/cells such as thymus and spleen (Figure 2A). The localization of NELL1 in the colonic mucosa was investigated by immunohistochemistry (Figures 2B and 2C). Immunoreactivity was confined to large mononuclear cells in the lamina propria. In Western blot experiments using colonic biopsy specimen from normal controls and CD patients (Figure 2E), the antibody recognized a single 90 kDa band corresponding to the correct size of the annotated NELL1 transcript (AK127805). Real-time quantitative PCR revealed no significant difference between normal and patient tissue (data not shown).
###end p 36
###begin title 37
Expression and localization of NELL1.
###end title 37
###begin p 38
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 126 130 123 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACTB</italic>
(A) Transcript levels of NELL1 in a set of different tissues were quantified by RT-PCR. Parallel amplification of beta-actin (ACTB) is shown. Expression and localization of the NELL1 protein in healthy colonic tissue is demonstrated in sections B (20x) and C (40x; bar = 10 microm) by immunohistochemistry. Immunoreactivity is confined to mononuclear/lymphocytic cells in the lamina propria (brown DAB reaction product, arrows). A control without the primary antibody is shown in section D. No major expression differences between colonic specimen from normal controls (N) and Crohn disease (CD) were detected in the Western blot (section E) with the same antibody as applied in sections B and C. The single detected band (90 kDa) corresponds to the predicted molecular weight of the isoform encoded by GenBank AK127805 (UniProt accession number Q92832).
###end p 38
###begin title 39
Fine Mapping of 5p13.1
###end title 39
###begin p 40
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5p13.1</italic>
###xml 60 66 60 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTGER4</italic>
###xml 218 226 218 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000691.s014">Table S6</xref>
###xml 228 237 228 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000691.s013">Figure S5</xref>
The 650 kb susceptibility region on 5p13.1, upstream of the PTGER4 gene, was subjected to fine mapping in panels B (1 SNP/24 kb) and D (1 SNP/3 kb). Several SNPs showed a consistent disease association in both panels (Table S6, Figure S5). The strongest effect in the combined case-control panel (A+B) was seen for SNP rs1553575 (odds ratio for homozygotes of the common G allele: 1.78; 95% CI: 1.32-2.40).
###end p 40
###begin p 41
###xml 49 55 49 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5p13.1</italic>
###xml 135 143 135 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000691.s015">Table S7</xref>
Interestingly, the gender-stratified analysis of 5p13.1 SNPs showed that the association signal was stronger in females than in males (Table S7), suggesting that females carrying the predisposing allele(s) of this locus are at higher risk to develop Crohn disease than their male counterparts. To have comparable power, the same number of male and female individuals were randomly drawn from the combined panel (378 controls, 343 cases).
###end p 41
###begin title 42
Interaction with Known Disease Loci
###end title 42
###begin p 43
###xml 274 279 274 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 304 310 304 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5p13.1</italic>
###xml 420 425 420 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 450 454 450 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 520 527 520 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATG16L1</italic>
###xml 547 551 547 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLG5</italic>
###xml 584 588 584 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IBD5</italic>
###xml 620 624 620 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Rioux1">[11]</xref>
###xml 626 630 626 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Fisher1">[29]</xref>
Logistic regression analysis and a Breslow-Day test for odds ratio heterogeneity were used to analyse the full German case-control panel (A+B) for potential epistatic effects. No statistically significant interactions were observed, neither between polymorphisms within the NELL1 gene (rs1793004) or the 5p13.1 region (rs1992660 and rs1992662), nor between these loci and any of the known disease-associated variants in IL23R (rs11209026/Arg381Gln), NOD2 (rs2066844/Arg702Trp, rs2066845/Gly908Arg, rs2066847/Leu1007fs), ATG16L1 (rs2241880/T300A), DLG5 (rs1248696/Arg30Gln), or in the IBD5 region (tagging SNP IGR2063_b1 [11], [29]).
###end p 43
###begin title 44
Discussion
###end title 44
###begin p 45
###xml 19 24 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 308 312 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Parkes1">[30]</xref>
###xml 314 318 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-1">[31]</xref>
###xml 373 378 373 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 619 624 619 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 743 745 743 745 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 329 337 <span type="species:ncbi:9606">patients</span>
We have identified NELL1 as a novel disease gene for Crohn disease (CD), a result that was obtained in a genome-wide case-control association scan with 116,161 SNPs and by extensive replication in three independent samples from three distinct ethnicities. In a recently published GWAS from the UK population [30], [31] (1,748 CD patients and 2,938 controls genotyped), the NELL1 region was covered with 263 SNPs (see ). Of these, 23 SNPs were significantly associated with CD (p<0.05 under an additive or general model) and six SNPs had a p<0.01: rs7122630, rs4475916, rs7115151, rs11025862, rs2063913, rs11026037. The NELL1 region was not subjected to replication in the UK scan, since none of the 23 SNPs fell below the chosen cut-off (p<010-5).
###end p 45
###begin p 46
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 124 130 124 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5p13.1</italic>
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Libioulle1">[18]</xref>
###xml 217 221 217 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 226 230 226 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5q31</italic>
###xml 312 316 312 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Nicolae1">[32]</xref>
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Barrett1">[33]</xref>
###xml 348 355 348 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000691-t004">Table 4</xref>
###xml 415 420 415 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 420 424 420 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Duerr1">[17]</xref>
###xml 430 434 430 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLG5</italic>
###xml 434 438 434 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Stoll1">[12]</xref>
###xml 444 451 444 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATG16L1</italic>
###xml 451 455 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Hampe2">[15]</xref>
###xml 519 526 519 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATG16L1</italic>
###xml 598 606 596 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000691.s016">Table S8</xref>
###xml 658 666 656 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post-hoc</italic>
###xml 808 815 806 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATG16L1</italic>
###xml 817 822 815 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 827 831 825 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLG5</italic>
###xml 853 860 851 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000691-t004">Table 4</xref>
###xml 925 929 923 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLG5</italic>
###xml 1006 1010 1004 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLG5</italic>
###xml 1030 1034 1028 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Lin1">[34]</xref>
###xml 1035 1039 1033 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Friedrichs1">[42]</xref>
###xml 1083 1087 1081 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLG5</italic>
###xml 1183 1187 1181 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Stoll1">[12]</xref>
###xml 1460 1464 1458 1462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLG5</italic>
###xml 1531 1535 1529 1533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Romeo1">[43]</xref>
###xml 1570 1574 1568 1572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLG5</italic>
###xml 1656 1660 1654 1658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Noble1">[44]</xref>
###xml 1661 1665 1659 1663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Torok1">[46]</xref>
###xml 1748 1752 1746 1750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLG5</italic>
###xml 1752 1756 1750 1754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Biank1">[13]</xref>
###xml 1758 1762 1756 1760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Lin1">[34]</xref>
###xml 1764 1768 1762 1766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Russell1">[40]</xref>
###xml 1769 1773 1767 1771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Friedrichs1">[42]</xref>
###xml 2110 2114 2108 2112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Friedrichs2">[47]</xref>
###xml 574 579 <span type="species:ncbi:9606">Human</span>
###xml 1900 1908 <span type="species:ncbi:9606">patients</span>
In addition to identifying NELL1 as a CD risk factor, we also replicated the disease association recently described for the 5p13.1 region [18]. The genome-wide scan also confirmed two of the previously known CD loci, NOD2 and 5q31, but it should be pointed out that the marker set only covered 31% of the genome [32], [33]. As has been detailed in Table 4, the previously established disease association of neither IL23R[17], nor DLG5[12], nor ATG16L1[15], were detected. However, not a single SNP, for example, in the ATG16L1 gene was present on the Affymetrix GeneChip(R) Human Mapping 100K Set (Table S8) and coverage of all these genes was low. Targeted post-hoc genotyping of the relevant SNPs in the German screening and replication panel was therefore carried out and confirmed the CD associations of ATG16L1, IL23R and DLG5 in our study sample (Table 4). We replicated the association of a haplotype A-tagging SNP in DLG5 which is supported by several other replications of the association between DLG5 and CD association [34]-[42]. Results for the two nonsynonymous SNPs in DLG5 were not reaching significance. However, as it has been speculated in our original description [12], we do not consider these SNPs as causative at this point. They are either part of a larger number of putatively causative SNPs not yet discovered or mere additional markers for unknown causative variants. We expect further relevant, hitherto unknown and rare variants in DLG5 that may only be detectable by large-scale sequencing of the gene [43]. It should also be noted that the DLG5 association has not been replicated in each and every population analysed so far [44]-[46]. Recent studies have proposed gender- and/or age at onset-related associations of DLG5[13], [34], [40]-[42] that would require exact matching of the study groups to become detectable. Our sample used in this study contained mainly CD patients with disease onset during early adulthood (average age at onset>22 years). This may have contributed to a replication that was weaker than the original description in statistical terms (for review see [47]).
###end p 46
###begin p 47
###xml 50 57 50 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATG16L1</italic>
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 69 73 69 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLG5</italic>
###xml 265 272 265 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATG16L1</italic>
###xml 287 292 287 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
The targeted replication of the CD association of ATG16L1, IL23R and DLG5 also serves to illustrate the highly conservative criteria employed in our study, which may have resulted in an under-appreciation of most initial association findings. Using these criteria, ATG16L1/Thr300Ala and IL23R/Arg381Gln would not have been included in the follow-up because the p-values of the two variants (0.014 for Thr300Ala and 0.0027 for Arg381Gln) both exceeded the cut-off of 0.0021 (attained by rs3790889 as number 200 of the ranked SNP list). Therefore, future efforts to replicate the major findings of our study should also include those SNPs that yielded a significant p-value in only one of the replication panels.
###end p 47
###begin p 48
###xml 4 45 4 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neural epidermal growth-factor-like (nel)</italic>
###xml 152 157 152 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 190 194 190 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Matsuhashi1">[48]</xref>
###xml 195 199 195 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Luce1">[50]</xref>
###xml 460 464 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Kuroda1">[51]</xref>
###xml 541 545 538 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Kuroda2">[52]</xref>
###xml 888 896 885 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000691-g003">Figure 3</xref>
###xml 898 902 895 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Kuroda1">[51]</xref>
###xml 1027 1031 1024 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Tan1">[53]</xref>
###xml 1346 1350 1343 1347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Bornstein1">[54]</xref>
###xml 1352 1356 1349 1353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Chen1">[55]</xref>
###xml 1492 1496 1489 1493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Voorberg1">[56]</xref>
###xml 1543 1547 1540 1544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Kuroda1">[51]</xref>
###xml 105 112 <span type="species:ncbi:9031">chicken</span>
###xml 135 140 <span type="species:ncbi:9606">human</span>
The neural epidermal growth-factor-like (nel) gene was first detected in neural tissue from an embryonic chicken cDNA library, and its human orthologue NELL1 was later discovered in B-cells [48]-[50]. The arrangement of the functional domains of the 810 aa protein bears resemblance to thrombospondin-1 (TSP-1) and consists of a thrombospondin N-terminal domain (TSPN) and several von Willebrand factor, type C (VWC), and epidermal growth-factor (EGF) domains [51]. As NELL1 binds to, and is phosphorylated by, PKC-beta1 via the EGF domains [52], it has been suggested that this protein belongs to a novel class of cell-signalling ligand molecules critical for growth and development. Re-sequencing and fine mapping revealed several non-synonymous SNPs of which the known Q82R variant and the novel R136S and A153T variants affect the TSPN domain, while R354W is located in a VWC domain (Figure 3) [51]. A153T is close to two highly conserved C-terminal cysteines forming a disulfide bond in the TSPN domain structure of TSP-1 [53] and may cause local conformational changes due to its buried position in the molecule. Generally, the TSPN domain has been shown to serve as a protein-protein interaction module, which binds membrane proteins and proteoglycans and exhibits versatile cell-specific effects on adhesion, migration, and proliferation [54], [55]. Since VWC domains occur in numerous proteins of diverse functions and are generally assumed to be involved in protein oligomerization [56], R354W may interfere with NELL1 trimerization [51].
###end p 48
###begin title 49
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> In silico</italic>
 In silico protein analysis.
###end title 49
###begin p 50
Domain architectures of NELL1/NELL2 and TSP1. The positions of variant amino acids are annotated. Abbreviations are as follows: SP: signal peptide; TSPN: thrombospondin N-terminal domain; CC: coiled-coil region; VWC: von Willebrand factor, type C domain; EGF: EGF domain; TSP-3: thrombospondin-3 repeat; TSP_C: thrombospondin C-terminal domain.
###end p 50
###begin p 51
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 114 118 114 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Zhang1">[57]</xref>
###xml 123 128 123 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 211 215 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Desai1">[58]</xref>
###xml 344 348 344 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Abitbol1">[59]</xref>
###xml 349 353 349 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Compston1">[61]</xref>
###xml 355 361 355 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTGER4</italic>
###xml 417 423 417 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5p13.1</italic>
###xml 481 486 481 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 502 506 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Desai1">[58]</xref>
###xml 578 583 578 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 588 594 588 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5p13.1</italic>
###xml 42 57 <span type="species:ncbi:10090">transgenic mice</span>
###xml 294 302 <span type="species:ncbi:9606">patients</span>
###xml 497 501 <span type="species:ncbi:10090">mice</span>
Bone development is severely disturbed in transgenic mice, where over-expression of NELL1 leads to craniosynostis [57] and NELL1 deficiency manifests in skeletal defects due to reduced chondro- and osteogenesis [58]. Interestingly, osteopenia and osteoporosis are leading co-morbidities in IBD patients, even without the use of glucocorticoids [59]-[61]. PTGER4, which has been suggested as the causative gene in the 5p13.1 locus, is among the key genes that are down-regulated in NELL1-deficient mice [58]. However, no statistical interaction was seen in our study between the NELL1 and 5p13.1 SNPs.
###end p 51
###begin p 52
###xml 376 380 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Yamazaki1">[14]</xref>
###xml 382 386 382 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Duerr1">[17]</xref>
###xml 586 591 586 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGB6</italic>
###xml 640 644 637 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Jenkins1">[62]</xref>
###xml 750 754 747 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Monteleone1">[63]</xref>
###xml 756 760 753 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Waetzig1">[64]</xref>
###xml 842 846 839 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRM8</italic>
###xml 909 915 906 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GRIN3A</italic>
###xml 926 932 923 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPP3R2</italic>
###xml 1109 1115 1106 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNF618</italic>
###xml 1173 1178 <span type="species:ncbi:9606">human</span>
The replication criteria used in our study were particularly strict and required a significant p-value in both, the family-based and the case-control association test in two different populations. Other studies used less stringent criteria for the replication of genome-wide association findings, and based their conclusions upon a single independent case control sample only [14], [17]. With such criteria, several additional SNPs would have been considered replicated in our study, some of which point towards genes putatively involved in the pathophysiology of IBD. Integrin beta 6 (ITGB6), for example, regulates activation of TGF-beta [62], a cytokine that has been established as an anti-inflammatory regulator in TNF-related CD pathopysiology [63], [64]. Two hits point towards the glutamate pathway, namely glutamate receptor type 8 (GRM8) and glutamate receptor, ionotropic, N-methyl-D-aspartate 3A (GRIN3A, formerly PPP3R2). Normal glutamate metabolism has been found to be important for the maintenance of intestinal function. Finally, SNP rs7868736 is located approximately 100 kb upstream of the ZNF618 gene encoding a zinc finger protein clearly expressed in human colon.
###end p 52
###begin p 53
###xml 140 145 140 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 165 172 165 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11p15.1</italic>
###xml 226 232 226 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5p13.1</italic>
###xml 270 276 270 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTGER4</italic>
###xml 307 312 307 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
In summary, we have successfully performed a systematic genome-wide association scan in Crohn disease that led to the identification of the NELL1 gene on chromosome 11p15.1 as a novel susceptibility gene for IBD. We confirmed 5p13.1 as a CD-associated locus relating to PTGER4 that is probably regulated by NELL1.
###end p 53
###begin title 54
Methods
###end title 54
###begin title 55
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient Recruitment
###end title 55
###begin p 56
###xml 126 130 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Stoll1">[12]</xref>
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Hampe2">[15]</xref>
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Croucher1">[65]</xref>
###xml 144 148 144 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Hampe3">[66]</xref>
###xml 320 324 320 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Hampe2">[15]</xref>
###xml 409 414 409 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 661 668 661 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000691-t001">Table 1</xref>
###xml 854 858 854 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-LennardJones1">[67]</xref>
###xml 860 864 860 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Truelove1">[68]</xref>
###xml 1091 1095 1091 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Krawczak1">[25]</xref>
###xml 7 15 <span type="species:ncbi:9606">patients</span>
###xml 420 428 <span type="species:ncbi:9606">patients</span>
###xml 987 995 <span type="species:ncbi:9606">patients</span>
German patients and controls in panels A, B, and C partially overlap with samples that have been used in other studies before [12], [15], [65], [66]. Panels A and B almost completely overlap with the panels (also termed panel A and B) that were used in a recently published IBD association screen of non-synonymous SNPs [15]. In this non-synonymous SNP scan no coding SNPs that were evaluable were located in NELL1. All patients were recruited at the Charite University Hospital (Berlin, Germany) and the Department of General Internal Medicine of the Christian-Albrechts-University (Kiel, Germany), with the support of the German Crohn and Colitis Foundation (Table 1). Clinical, radiological and endoscopic (i.e. type and distribution of lesions) examinations were required to unequivocally confirm the diagnosis of Crohn disease or ulcerative colitis [67], [68], and histological findings also had to be confirmative of, or compatible with, the diagnosis. In the case of uncertainty, patients were excluded from the study. German control individuals were obtained from the POPGEN biobank [25].
###end p 56
###begin p 57
###xml 61 65 61 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Onnie1">[69]</xref>
###xml 7 15 <span type="species:ncbi:9606">patients</span>
The UK patients (Panel E) were recruited as described before [69]; UK controls were obtained from the 1958 British Birth Cohort ().
###end p 57
###begin p 58
The French/Canadian trios (Panel D) were sampled from the Quebec founder population (QFP). Membership of the founder population was defined as having four grandparents with French Canadian family names who were born in the Province of Quebec, Canada, or in adjacent areas of the Provinces of New Brunswick and Ontario, or in New England or New York State (USA).
###end p 58
###begin p 59
###xml 53 65 <span type="species:ncbi:9606">participants</span>
Informed written consent was obtained from all study participants. All collection protocols were approved by the institutional review committees of the participating centres.
###end p 59
###begin title 60
SNP Genotyping with the Affymetrix 100k Gene Chip Array
###end title 60
###begin p 61
###xml 822 828 814 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 828 832 820 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Matsuzaki1">[22]</xref>
###xml 82 87 <span type="species:ncbi:9606">Human</span>
Genotyping of cases and controls was carried out using the Affymetrix GeneChip(R) Human Mapping 50K Xba and Hind Arrays (Affymetrix, Santa Clara, CA, USA). Genotypes were called by the GeneChip(R) DNA Analysis Software (GDAS v2.0, Affymetrix). Gender was verified by counting the heterozygous SNPs on the X chromosome. Quality checks further comprised the verification of individual sample call rates (>/=90%) and, to ensure that no samples were confused, the 31 identical SNPs present on both chips were checked for identical genotypes for the same individual. SNPs that had a low genotyping success rate (<90%), were monomorphic, or deviated from Hardy-Weinberg equilibrium (p</=0.01) were eliminated from subsequent analyses. Experimental details concerning the genotyping of the 100k SNP set are provided in Matsuzaki et al.[22].
###end p 61
###begin title 62
Follow-up Genotyping and Sequencing
###end title 62
###begin p 63
###xml 131 135 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Hampe2">[15]</xref>
###xml 321 325 312 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Hampe4">[70]</xref>
###xml 826 830 808 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Teuber1">[71]</xref>
###xml 853 857 835 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 869 873 851 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 885 889 867 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 901 905 883 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLG5</italic>
###xml 916 920 898 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLG5</italic>
###xml 933 937 915 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLG5</italic>
###xml 947 954 929 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATG16L1</italic>
###xml 1013 1017 995 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Stoll1">[12]</xref>
###xml 1019 1023 1001 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Hampe2">[15]</xref>
###xml 1025 1029 1007 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Hampe5">[72]</xref>
###xml 1031 1036 1013 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 1048 1053 1030 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 1069 1074 1051 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 1348 1351 1330 1333 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HWE</sub>
###xml 1361 1369 1343 1351 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">controls</sub>
SNPlextrade mark (Applied Biosystems, Foster City, CA, USA) genotyping of panels A, B, and C was carried out as recently described [15]. Genotype concordance rates for SNPs rs1793004, rs1992660, and rs1992662 were checked using TaqMan (Applied Biosystems) as an independent genotyping technology on an automated platform [70] and the functionally tested assays C____392093_10, C__11472026_10, and C__11472042_10. All three concordance rates were >98%, excluding genotyping errors as a potential source of false-positive associations. The same three TaqMan assays were also used to genotype panels C and E. Genotypes for panel D were generated at Genizon BioSciences using the Illumina GoldenGatetrade mark platform (Illumina, San Diego, CA, USA). All process data were logged into, and administered by, a database-driven LIMS [71]. TaqMan genotyping of NOD2/Arg702Trp, NOD2/Gly908Arg, NOD2/Leu1007fs, DLG5/Arg30Gln, DLG5/Pro1371Gln, DLG5/e26, and ATG16L1/Thr300Ala was performed using previously described assays [12], [15], [72]. IL23R/Arg381Gln, NELL1/rs8176785, and NELL1/rs8176786 were genotyped in panels A, B, C, and E using the functionally tested assay C___1272298_10, C___3203197_10, and C__32647553_10, respectively (Applied Biosystems). Prior to statistical analyses, the same cut-off criteria as described above for the 100k analysis (pHWE>0.01, MAFcontrols>0, callrate>/=90%) were applied to the SNPs under study.
###end p 63
###begin p 64
###xml 177 185 168 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000691.s009">Table S1</xref>
###xml 260 264 251 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Weckx1">[73]</xref>
Sequencing of genomic DNA was performed using Applied Biosystems BigDyetrade mark chemistry according to the supplier's recommendations (for primer sequences, see supplementary Table S1). Traces were inspected for the presence of SNPs and InDels using novoSNP [73].
###end p 64
###begin title 65
Statistical Analysis
###end title 65
###begin p 66
###xml 80 84 80 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Franke1">[74]</xref>
###xml 200 204 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Barrett2">[75]</xref>
###xml 402 411 402 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000691.s008">Figure S7</xref>
###xml 442 451 442 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000691.s004">Figure S3</xref>
###xml 816 820 816 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Dudbridge1">[76]</xref>
###xml 835 839 835 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Stephens1">[77]</xref>
###xml 841 845 841 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Stephens2">[78]</xref>
Genome-wide data analysis was carried out using an updated version of GENOMIZER [74]. Association hits that passed the quality criteria were extracted using the "GenomizerHits" tool (). Haploview 4.0 [75] was used for association analysis, transmission disequilibrium tests, and LD quantification of the replication data. Fisher's exact test was used when appropriate. The supplementary p-value plots (Figure S7) and quantile-quantile plots (Figure S3) were created using R (). Single-marker disease associations and possible marker-marker interactions were assessed for statistical significance by means of logistic regression analysis (forward selection), as implemented in the procedure LOGISTIC of the SAS software package (SAS Institute, Cary NC, USA). Haplotype analyses were carried out using COCAPHASE 2.403 [76] and PHASE 2.1 [77], [78].
###end p 66
###begin title 67
RT-PCR, Western Blot and Immunohistochemistry
###end title 67
###begin p 68
###xml 164 169 164 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NELL1</italic>
###xml 190 214 190 214 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">ACCTTCCTGGGTTATATCGCTGTG</named-content>
###xml 233 253 233 253 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TCTCGCAGTGGCTTCCTGTG</named-content>
For the assessment of tissue-specific expression patterns, a commercial tissue panel was employed (Clontech, Palo Alto, CA, USA). Primers used for amplification of NELL1 were (NELL1_14-16_F ACCTTCCTGGGTTATATCGCTGTG and NELL1_14-16_R TCTCGCAGTGGCTTCCTGTG, expected amplicon length: 285 bp). The following conditions were applied: denaturation for 5 min at 95degreesC; 40 cycles of 30 sec at 95degreesC, 20 sec at 60degreesC, 45 sec at 72degreesC; final extension for 10 min at 72degreesC. To confirm the use of equal amounts of RNA in each experiment, all samples were checked in parallel for beta-actin mRNA expression. All amplified DNA fragments were analyzed on 2% agarose gels and subsequently documented by a BioDoc Analyzer (Biometra, Gottingen, Germany).
###end p 68
###begin p 69
###xml 88 96 <span type="species:ncbi:9606">patients</span>
###xml 466 472 <span type="species:ncbi:9913">bovine</span>
###xml 595 600 <span type="species:ncbi:10090">mouse</span>
###xml 746 750 <span type="species:ncbi:9925">goat</span>
###xml 756 761 <span type="species:ncbi:10090">mouse</span>
Paraformaldehyde-fixed paraffin-embedded biopsies from normal controls (n = 6) and from patients with confirmed colonic CD (n = 6) were analysed. Two slides of each biopsy were stained with hematoxylin-eosin for routine histological evaluation. The other slides were subjected to a citrate-based antigen retrieval procedure, permeabilized by incubation with 0.1% Triton X-100 in 0.1M phosphate-buffered saline (PBS), washed three times in PBS and blocked with 0.75% bovine serum albumin in PBS for 20 minutes. Sections were subsequently incubated with the primary antibody (anti-NELL1, Abnova , mouse monoclonal) at a 1:500 dilution in 0.75% BSA overnight at 4degreesC. After washing in PBS, tissue-bound antibody was detected using biotinylated goat-anti mouse (Vector Laboratory, Burlingame, CA) followed by HRP-conjugated avidin, both diluted at 1:100 in PBS. Controls were included using irrelevant primary antibodies as well as omitting the primary antibodies using only secondary antibodies and/or HRP-conjugated avidin. No significant staining was observed with any of these controls (data not shown). Bound antibody was detected by standard chromogen technique (Vector Laboratory) and visualized by an Axiophot microscope (Zeiss, Jena, Germany). Pictures were captured by a digital camera system (Axiocam, Zeiss).
###end p 69
###begin p 70
###xml 49 53 49 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Waetzig2">[79]</xref>
###xml 210 218 <span type="species:ncbi:9606">patients</span>
Western blot analysis was performed as described [79]. In brief, 20 microg of protein lysates freshly derived from colonic biopsies of four healthy controls without any obvious intestinal pathology and four CD patients with confirmed ileal and colonic inflammation were lysed, separated by SDS polyacrylamide gel electrophoresis and transferred to PVDF membrane by standard techniques. NELL1 was detected using the same monoclonal anti-NELL1 antibody also employed for immunohistochemistry.
###end p 70
###begin title 71
In silico Protein Analysis
###end title 71
###begin p 72
###xml 19 38 19 38 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000691.s005">Figures S4A and S4B</xref>
###xml 641 649 641 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000691-g004">Figure 4</xref>
###xml 701 708 701 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000691.s001">Text S1</xref>
###xml 465 470 <span type="species:ncbi:9606">human</span>
Aligned sequences (Figures S4A and S4B) were retrieved from the UniProt database () and protein domain architectures taken from the NCBI conserved domain search website (). To predict the 3D structure of the N-terminal domain of NELL1, we explored the fold recognition results returned by the web servers GenTHREADER () and FFAS03 (). Based upon the very similar server predictions, a pair-wise sequence-structure alignment of NELL1 to the crystal structure of the human thrombospondin-1 N-terminal domain (TSPN) was constructed as input for the 3D-modeling server WHATIF (), which returned a structure model of the NELL1 N-terminal domain (Figure 4). Additional details are given in the supplements (Text S1).
###end p 72
###begin title 73
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> In silico</italic>
 In silico protein analysis.
###end title 73
###begin p 74
Computationally derived 3D structure model of the N-terminal domain of the NELL1 protein. The model was created using the TSPN (PDB code 1z78, chain A) as a structure template for NELL1. The locations of variant amino acids as well as of two cysteines forming a disulfide bridge are annotated.
###end p 74
###begin title 75
Supporting Information
###end title 75
###begin p 76
###xml 57 66 57 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
Supplementary methods, results, and discussion - Protein in silico analysis.
###end p 76
###begin p 77
(0.58 MB PDF)
###end p 77
###begin p 78
Click here for additional data file.
###end p 78
###begin p 79
Workflow diagram summarizing the different stages of the experiment.
###end p 79
###begin p 80
(0.22 MB PDF)
###end p 80
###begin p 81
Click here for additional data file.
###end p 81
###begin p 82
Power calculation for the present genome-wide association scan of 393 cases and 399 controls (a = 0.05). Five different allele frequencies in controls (p0) are shown: 50%, 30%, 20%, 10%, and 5%. The scan had e.g. 80% power to detect an Odds ratio of 1.6 assuming that 20% of the controls are exposed. Calculations were done using the software PS Power and Sample Size Calculations.
###end p 82
###begin p 83
(0.15 MB PDF)
###end p 83
###begin p 84
Click here for additional data file.
###end p 84
###begin p 85
###xml 614 622 614 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000691.s010">Table S2</xref>
Quantile-quantile plots (A) before and (B) after exclusion of lowquality SNPs (callrate<90%, pHWE<0.01, MAF>0.99). The ranked, observed Chi2-values of the allelic test are plotted against the values expected for sampling from a Chi2 distribution with one degree of freedom (the distribution expected under the null hypothesis). The inflation of the Chi2 distribution is significantly reduced by removing low-quality SNPs and there is no visible indication of population structure. The outlier in the upper right corner of the diagram B represents genuine association of SNP rs2076756 in the NOD2 gene with CD (see Table S2, Lead #1).
###end p 85
###begin p 86
(0.22 MB PDF)
###end p 86
###begin p 87
Click here for additional data file.
###end p 87
###begin p 88
###xml 131 136 <span type="species:ncbi:9606">human</span>
(A) Structure-based multiple sequence alignment of the N-terminal domains of NELL1 and NELL2 homologs and the N-terminal domain of human thrombospondin-1 (TSP-1). The DSSP secondary structure assignment of the TSPN structure (PDB code 1z78, chain A) is depicted at the top of the alignment. (B) Multiple sequence alignment of NELL1 and NELL2 homologs. Domain locations are represented as colored bars at the top of the alignment (green: VWC domain; pink: EGF-like domain). Alignment columns with more than 70% physicochemically similar amino acids are highlighted in blue boxes with white letters. Text labels point to the N-terminal signal peptide and the sequence variants, which are marked yellow in all homologs. Residue numbering in the alignment is based on complete protein sequences as derived from corresponding UniProt entries.
###end p 88
###begin p 89
(0.41 MB PDF)
###end p 89
###begin p 90
Click here for additional data file.
###end p 90
###begin p 91
Overview of the results for the 5p13.1 locus. (A) Plot of the negative common logarithm of the p-values of the different tiers across the 650 kb region. The red line shows the significance threshold of p = 0.05. Results of the two lead SNPs rs1992662 and rs1992660 are highlighted in pink color. The broad replicated peak between 40.29 Mb and 40.66 Mb localizes to a gene desert upstream of PTGER4. (B) Recombination rate in cM/Mb shows that the peak region is delineated by two sites of increased recombination. (C) Linkage-disequilibrium (LD) plot from HapMap, using the metrics D' and (D) r2. Genotypes of trios with northern and western European ancestry for 633 SNPs (CR> = 90%, MAF> = 1%, pHWE> = 0.01, Mendel errors> = 3) were retrieved from HapMap. Positions are from NCBI build 35.
###end p 91
###begin p 92
(1.36 MB PDF)
###end p 92
###begin p 93
Click here for additional data file.
###end p 93
###begin p 94
###xml 35 40 <span type="species:ncbi:9606">human</span>
Secondary structure prediction for human NELL1 (UniProt accession number Q92832). The PSIPRED web server produced the depicted prediction.
###end p 94
###begin p 95
(0.13 MB PDF)
###end p 95
###begin p 96
Click here for additional data file.
###end p 96
###begin p 97
###xml 306 314 306 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000691.s009">Table S1</xref>
The diagrams on the first page show the results of the whole genome association scan for Crohn disease and subsequent pages show the enlarged diagrams for each chromosome. The negative common logarithm of the p-values for the allelic test are shown. Only markers that passed the quality criteria listed in Table S1 were used for plotting (n = 92,387). "Outlier" SNP rs2076756 in the CARD15 gene (pCCA<10-12, 50.53 Mb) was omitted for illustration purposes. Marker positions are from NCBI build 34.
###end p 97
###begin p 98
(11.06 MB PDF)
###end p 98
###begin p 99
Click here for additional data file.
###end p 99
###begin p 100
Summary of the genome-wide association scan. Table (A) gives an overview of the SNP number and density per chromosome. Table (B) lists the distribution of the p-values in the genome-wide scan versus a randomized experiment, i.e. randomized affection status of individuals. CR: callrate in cases and controls, MAF: minor allele frequency in controls, pHWE: p-value for Hardy-Weinberg equilibrium in controls, QC: quality control, CCA: p-value of Chi2 test for alleles and genotypes (CCG), *excl. unmapped
###end p 100
###begin p 101
(0.12 MB PDF)
###end p 101
###begin p 102
Click here for additional data file.
###end p 102
###begin p 103
Top 200 CD-associated SNPs, ranked with respect to p-values obtained in an allele- (pCCA) or genotype-based (pCCG) case-control comparison in panel A. Also included are pCCA, pCCG, and the transmission disequilibrium test results (pTDT) for the replication panel B. Nucleotide positions refer to NCBI build 35. Markers with p< = 0.05 in either the case-control analysis or the transmission disequilibrium test (TDT) in replication panel B are highlighted in bold italics. SNPs with a significant result in both panel B tests are additionally marked by grey shading.
###end p 103
###begin p 104
(0.15 MB PDF)
###end p 104
###begin p 105
Click here for additional data file.
###end p 105
###begin p 106
###xml 320 328 320 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000691.s010">Table S2</xref>
###xml 643 646 643 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000691-Loftus1">[1]</xref>
Fine mapping of the CD association signal at the NELL1 locus in replication panels B and D. The p-values of the allele-based (pCCA) and genotype-based (pCCG) association analyses of the tagging SNPs are shown, pTDT is the p-value for the transmission disequilibrium test (TDT). Lead SNPs from the initial screening (see Table S2) are highlighted by grey shading, nonsynonymous SNPs in red color. Polymorphisms that are significant in either the TDT or the case-control analyses, are highlighted in bold italics and those significant in both are highlighted in blue color. Pairwise LD is listed using the metric r2 as calculated with Haploview [1] and minor allele frequencies (MAF) are listed for control individuals. Nucleotide positions refer to NCBI build 35.
###end p 106
###begin p 107
(0.14 MB PDF)
###end p 107
###begin p 108
Click here for additional data file.
###end p 108
###begin p 109
###xml 122 130 <span type="species:ncbi:9606">patients</span>
Summary of the mutation detection of NELL1. All 21 exons plus the promoter were resequenced in 47 unrelated Crohn disease patients. Five not yet annotated polymorphisms were identified, including the two nonsynonymous SNPs NELL1_02 and NELL1_03. Twenty-sex annotated SNPs were verified.
###end p 109
###begin p 110
(0.14 MB PDF)
###end p 110
###begin p 111
Click here for additional data file.
###end p 111
###begin p 112
Primer sequences used for the mutation detection of NELL1.
###end p 112
###begin p 113
(0.13 MB DOC)
###end p 113
###begin p 114
Click here for additional data file.
###end p 114
###begin p 115
###xml 162 177 162 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000691.s011">Table Legend S3</xref>
Fine mapping of the CD association signal at the 5p13.1 locus in replication panels B and D. The highlighting and the column headers are the same as described in Table Legend S3.
###end p 115
###begin p 116
(0.16 MB PDF)
###end p 116
###begin p 117
Click here for additional data file.
###end p 117
###begin p 118
Results of gender-stratified analysis for 5p13.1 SNPs. Only markers that showed a significant p-value in the single-point analysis of the two subgroups are shown. 378 controls and 343 CD cases were randomly drawn from each subgroup and odds ratios (OR) for carriership of the common allele are shown.
###end p 118
###begin p 119
(0.18 MB PDF)
###end p 119
###begin p 120
Click here for additional data file.
###end p 120
###begin p 121
###xml 74 81 74 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000691-t004">Table 4</xref>
SNP coverage of 100k Array for known IBD susceptibility loci. Variants of Table 4 were included (highlighted by grey shading) to calculate distances. Nucleotide positions refer to NCBI build 35 and the following gene regions were used: IL23R: 67002085-67095564, ATG16L1: 234447031-234491134, DLG5: 78895154-79030951, NOD2: 50509083-50545020.
###end p 121
###begin p 122
(0.16 MB PDF)
###end p 122
###begin p 123
Click here for additional data file.
###end p 123
###begin p 124
###xml 30 38 <span type="species:ncbi:9606">patients</span>
###xml 140 147 <span type="species:ncbi:9606">patient</span>
The authors wish to thank all patients, families and physicians for their cooperation. The cooperativeness of the German Crohns and Colitis patient association (Deutsche Morbus Crohn und Colitis Vereinigung e.V.) and of the contributing gastroenterologists are gratefully acknowledged. The authors wish to thank Tanja Wesse, Birthe Petersen, Tanja Henke, Anita Dietsch, Ilona Urbach, Rainer Vogler, and Melanie Friskovec, Kiel, and Dianne Soars, London, for expert technical help. The ongoing technical and logistic support and helpful discussions with Andrea Toeppel from Applied Biosystems, Tom Hemming Karlsen (Rikshospitalet, Oslo), and Marcus Will (Kiel) is especially acknowledged. We thank Drs A. Forbes, J. Sanderson and S. Fisher for case ascertainment and establishment of the UK CD database.
###end p 124
###begin title 125
References
###end title 125
###begin article-title 126
Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences.
###end article-title 126
###begin article-title 127
Genetics of Crohn disease, an archetypal inflammatory barrier disease.
###end article-title 127
###begin article-title 128
Familial occurrence of inflammatory bowel disease.
###end article-title 128
###begin article-title 129
###xml 87 95 <span type="species:ncbi:9606">patients</span>
The genetics of Crohn disease: complex segregation analysis of a family study with 265 patients with Crohn disease and 5,387 relatives.
###end article-title 129
###begin article-title 130
Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking.
###end article-title 130
###begin article-title 131
Genetics versus environment in inflammatory bowel disease: results of a British twin study.
###end article-title 131
###begin article-title 132
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.
###end article-title 132
###begin article-title 133
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.
###end article-title 133
###begin article-title 134
Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations.
###end article-title 134
###begin article-title 135
Functional variants of OCTN cation transporter genes are associated with Crohn disease.
###end article-title 135
###begin article-title 136
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease.
###end article-title 136
###begin article-title 137
Genetic variation in DLG5 is associated with inflammatory bowel disease.
###end article-title 137
###begin article-title 138
DLG5 R30Q variant is a female-specific protective factor in pediatric onset Crohn's disease.
###end article-title 138
###begin article-title 139
Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease.
###end article-title 139
###begin article-title 140
A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1.
###end article-title 140
###begin article-title 141
Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease.
###end article-title 141
###begin article-title 142
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.
###end article-title 142
###begin article-title 143
Novel Crohn Disease Locus Identified by Genome-Wide Association Maps to a Gene Desert on 5p13.1 and Modulates Expression of PTGER4.
###end article-title 143
###begin article-title 144
Confirmation of the role of ATG16l1 as a Crohn's disease susceptibility gene.
###end article-title 144
###begin article-title 145
Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis.
###end article-title 145
###begin article-title 146
A Nonsynonymous SNP in ATG16L1 Predisposes to Ileal Crohn's Disease and Is Independent of CARD15 and IBD5.
###end article-title 146
###begin article-title 147
Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays.
###end article-title 147
###begin article-title 148
Increasing the power and efficiency of disease-marker case-control association studies through use of allele-sharing information.
###end article-title 148
###begin article-title 149
SNP-based analysis of genetic substructure in the German population.
###end article-title 149
###begin article-title 150
###xml 40 48 <span type="species:ncbi:9606">patients</span>
PopGen: population-based recruitment of patients and controls for the analysis of complex genotype-phenotype relationships.
###end article-title 150
###begin article-title 151
Population structure, differential bias and genomic control in a large-scale, case-control association study.
###end article-title 151
###begin article-title 152
Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM).
###end article-title 152
###begin article-title 153
Circumventing multiple testing: a multilocus Monte Carlo approach to testing for association.
###end article-title 153
###begin article-title 154
Direct or indirect association in a complex disease: the role of SLC22A4 and SLC22A5 functional variants in Crohn disease.
###end article-title 154
###begin article-title 155
Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility.
###end article-title 155
###begin article-title 156
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.
###end article-title 156
###begin article-title 157
###xml 56 61 <span type="species:ncbi:9606">Human</span>
Coverage and characteristics of the Affymetrix GeneChip Human Mapping 100K SNP set.
###end article-title 157
###begin article-title 158
Evaluating coverage of genome-wide association studies.
###end article-title 158
###begin article-title 159
Gender related association of DLG5 variant R30Q with inflammatory bowel disease (IBD) in a familial IBD registry.
###end article-title 159
###begin article-title 160
Association of DLG5 R30Q variant with inflammatory bowel disease.
###end article-title 160
###begin article-title 161
DLG5 variants contribute to Crohn disease risk in a Canadian population.
###end article-title 161
###begin article-title 162
###xml 62 70 <span type="species:ncbi:9606">patients</span>
Association analysis of SLC22A4, SLC22A5 and DLG5 in Japanese patients with Crohn disease.
###end article-title 162
###begin article-title 163
Genetic variants of DLG5 gene, E514Q, P979L, G1066G, and P1371Q in a familial inflammatory bowel disease (IBD) registry.
###end article-title 163
###begin article-title 164
A large, nationwide, case-control study for the association of DLG5, OCTN1/2 and CARD15 with Inflammatory Bowel Diseases in the Netherlands.
###end article-title 164
###begin article-title 165
The contribution of the DLG5 113A variant in early-onset inflammatory bowel disease.
###end article-title 165
###begin article-title 166
Genetic susceptibility has a more important role in pediatric-onset Crohn's disease than in adult-onset Crohn's disease.
###end article-title 166
###begin article-title 167
###xml 130 133 <span type="species:ncbi:9606">men</span>
Evidence of transmission ratio distortion of DLG5 R30Q variant in general and implication of an association with Crohn disease in men.
###end article-title 167
###begin article-title 168
Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL.
###end article-title 168
###begin article-title 169
DLG5 variants do not influence susceptibility to inflammatory bowel disease in the Scottish population.
###end article-title 169
###begin article-title 170
Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD.
###end article-title 170
###begin article-title 171
Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease.
###end article-title 171
###begin article-title 172
Role of discs large homolog 5.
###end article-title 172
###begin article-title 173
###xml 119 124 <span type="species:ncbi:9031">chick</span>
New gene, nel, encoding a Mr 91 K protein with EGF-like repeats is strongly expressed in neural tissues of early stage chick embryos.
###end article-title 173
###begin article-title 174
###xml 121 126 <span type="species:ncbi:9031">chick</span>
New gene, nel, encoding a M(r) 93 K protein with EGF-like repeats is strongly expressed in neural tissues of early stage chick embryos.
###end article-title 174
###begin article-title 175
The neuronal EGF-related genes NELL1 and NELL2 are expressed in hemopoietic cells and developmentally regulated in the B lineage.
###end article-title 175
###begin article-title 176
Biochemical characterization and expression analysis of neural thrombospondin-1-like proteins NELL1 and NELL2.
###end article-title 176
###begin article-title 177
Involvement of epidermal growth factor-like domain of NELL proteins in the novel protein-protein interaction with protein kinase C.
###end article-title 177
###begin article-title 178
The structures of the thrombospondin-1 N-terminal domain and its complex with a synthetic pentameric heparin.
###end article-title 178
###begin article-title 179
Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1.
###end article-title 179
###begin article-title 180
The cell biology of thrombospondin-1.
###end article-title 180
###begin article-title 181
Assembly and routing of von Willebrand factor variants: the requirements for disulfide-linked dimerization reside within the carboxy-terminal 151 amino acids.
###end article-title 181
###begin article-title 182
###xml 20 35 <span type="species:ncbi:10090">transgenic mice</span>
Craniosynostosis in transgenic mice overexpressing Nell-1.
###end article-title 182
###begin article-title 183
###xml 16 20 <span type="species:ncbi:10090">mice</span>
Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects.
###end article-title 183
###begin article-title 184
###xml 29 37 <span type="species:ncbi:9606">patients</span>
Metabolic bone assessment in patients with inflammatory bowel disease.
###end article-title 184
###begin article-title 185
###xml 13 21 <span type="species:ncbi:9606">patients</span>
Bone loss in patients with inflammatory bowel disease: a prospective study.
###end article-title 185
###begin article-title 186
###xml 16 24 <span type="species:ncbi:9606">patients</span>
Osteoporosis in patients with inflammatory bowel disease.
###end article-title 186
###begin article-title 187
Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury.
###end article-title 187
###begin article-title 188
###xml 55 63 <span type="species:ncbi:9606">patients</span>
Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease.
###end article-title 188
###begin article-title 189
Soluble tumor necrosis factor (TNF) receptor-1 induces apoptosis via reverse TNF signaling and autocrine transforming growth factor-beta1.
###end article-title 189
###begin article-title 190
Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations.
###end article-title 190
###begin article-title 191
A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort.
###end article-title 191
###begin article-title 192
Classification of inflammatory bowel disease.
###end article-title 192
###begin article-title 193
Course and prognosis of Crohn's disease.
###end article-title 193
###begin article-title 194
Associations of allelic variants of the multidrug resistance gene (ABCB1 or MDR1) and inflammatory bowel disease and their effects on disease behavior: a case-control and meta-analysis study.
###end article-title 194
###begin article-title 195
An integrated system for high throughput TaqMan based SNP genotyping.
###end article-title 195
###begin article-title 196
Improving quality control and workflow management in high-throughput single-nucleotide polymorphism genotyping environments.
###end article-title 196
###begin article-title 197
Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study.
###end article-title 197
###begin article-title 198
novoSNP, a novel computational tool for sequence variation discovery.
###end article-title 198
###begin article-title 199
GENOMIZER: an integrated analysis system for genome-wide association data.
###end article-title 199
###begin article-title 200
Haploview: analysis and visualization of LD and haplotype maps.
###end article-title 200
###begin article-title 201
Pedigree disequilibrium tests for multilocus haplotypes.
###end article-title 201
###begin article-title 202
###xml 54 59 <span type="species:ncbi:9606">human</span>
Haplotype variation and linkage disequilibrium in 313 human genes.
###end article-title 202
###begin article-title 203
A comparison of bayesian methods for haplotype reconstruction from population genotype data.
###end article-title 203
###begin article-title 204
p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease.
###end article-title 204
###begin p 205
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 205
###begin p 206
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was supported by the German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN), the German Research Council (Ha3091/1-2), by the POPGEN biobank, the German Research Council, the Wellcome Trust and CORE (UK). We acknowledge use of genotype data from the British 1958 Birth Cohort DNA collection, funded by Medical Research Council grant G0000934 and Wellcome Trust grant 068545/Z/02.
###end p 206

